FORMULA SYSTEMS (1985) LTD
Business
Formula Systems (1985) Ltd is a global information technology parent company that invests in and manages a group of IT services and software companies and directs their strategy while providing management, technical and marketing support. Its investees design, develop and deliver IT consulting, systems integration, cloud and infrastructure services, low-code and proprietary software platforms, insurance core systems, payroll and HR software, digital advertising and staffing solutions. It operates through subsidiaries and equity investees including Matrix, Sapiens, Magic Software, Michpal, Zap Group, InSync, TSG Systems and others organized into segments for IT services, proprietary software, insurance solutions, staffing and digital platforms. Formula serves customers worldwide, with significant activity in Israel, the United States, Europe and APAC, and distributes via direct sales, channel partners, system integrators and digital platforms.
Summary from filing dated 2025-05-15
Financials
Consolidated Statement of Income
| Concept | Trend | Dec 31, 2025 2025-12-31 | Dec 31, 2024 2024-12-31 | Dec 31, 2023 2023-12-31 |
|---|---|---|---|---|
| Profit or loss [abstract] | — | — | — | |
| Revenues: | — | — | — | |
| Proprietary software products and related services | 209 | 186 | 179 | |
| Software services and other | 2,418 | 2,033 | 1,932 | |
| Total revenues | 2,627 | 2,218 | 2,110 | |
| Cost of revenues: | — | — | — | |
| Proprietary software products and related services | 89 | 76 | 78 | |
| Software services and other | 2,019 | 1,696 | 1,612 | |
| Total cost of revenues | 2,108 | 1,773 | 1,689 | |
| Gross profit | 519 | 446 | 421 | |
| Research and development expenses, net | 20 | 18 | 14 | |
| Selling, marketing, general and administrative expenses | 312 | 250 | 249 | |
| Other income, net | 9 | 5 | — | |
| Operating income | 196 | 183 | 158 | |
| Financial expenses | 64 | 35 | 36 | |
| Financial income | 14 | 10 | 11 | |
| Pre-tax income before share of profits of companies accounted for at equity, net | 146 | 159 | 133 | |
| Share of profits of companies accounted for at equity, net | 4 | 2 | 773,000 | |
| Taxes on income | 40 | 39 | 32 | |
| Net income from continued operations | 110 | 122 | 102 | |
| Net income from discontinued operations | 559 | 72 | 64 | |
| Net income | 669 | 194 | 166 | |
| Net income (loss) attributable to non-controlling interests: | — | — | — | |
| From continued operations | 73 | 74 | 66 | |
| From discontinued operations | −10 | 40 | 35 | |
| Net income to Non-controlling interests | 63 | 114 | 102 | |
| Net income attributable to Formula’s shareholders: | — | — | — | |
| From continued operations | 37 | 49 | 36 | |
| From discontinued operations | 570 | 31 | 28 | |
| Net income attributable to Formula’s shareholders | 606 | 80 | 64 | |
| Earnings per share from continued operations (basic) (in Dollars per share) | 2.39 | 3.18 | 2.34 | |
| Earnings per share from discontinued operations (basic) (in Dollars per share) | 37.24 | 2.04 | 1.85 | |
| Earnings per share (basic) (in Dollars per share) | 39.63 | 5.22 | 4.19 | |
| Earnings per share from continued operations (diluted) (in Dollars per share) | 2.3 | 3.1 | 2.3 | |
| Earnings per share from discontinued operations (diluted) (in Dollars per share) | 36.09 | 1.99 | 1.82 | |
| Earnings per share (diluted) (in Dollars per share) | 38.39 | 5.09 | 4.12 | |
| Number of shares used in computing: | — | — | — | |
| Earnings per share (basic) (in Shares) | 15 | 15 | 15 | |
| Earnings per share (diluted) (in Shares) | 16 | 16 | 15 |
Consolidated Balance Sheet
| Concept | Trend | Dec 31, 2025 2025-12-31 | Dec 31, 2024 2024-12-31 |
|---|---|---|---|
| CURRENT ASSETS: | — | — | |
| Cash and cash equivalents | 1,280 | 508 | |
| Short-term deposits | 372,000 | 55 | |
| Trade receivables, (net from expected credit losses of $14,942 and $18,106 as of December 31, 2025 and 2024, respectively) | 774 | 803 | |
| Prepaid expenses and other accounts receivable | 81 | 90 | |
| Inventories | 30 | 31 | |
| Total current assets | 2,166 | 1,487 | |
| NON-CURRENT ASSETS: | — | — | |
| Long-term investments and receivables | 50 | 50 | |
| Financial assets measured at fair value through profit or loss | 305 | 5 | |
| Investments in companies accounted for at equity | 49 | 39 | |
| Property, plant and equipment, net | 48 | 52 | |
| Right-of-use assets | 145 | 156 | |
| Deferred taxes | 27 | 34 | |
| Intangible assets, net | 148 | 217 | |
| Goodwill | 646 | 975 | |
| Total non-current assets | 1,417 | 1,528 | |
| Total assets | 3,583 | 3,015 | |
| CURRENT LIABILITIES: | — | — | |
| Loans from banks and others | 178 | 142 | |
| Debentures | 77 | 87 | |
| Current maturities of lease liabilities | 43 | 45 | |
| Trade payables | 368 | 296 | |
| Deferred revenues | 158 | 174 | |
| Employees and payroll accrual | 236 | 235 | |
| Other accounts payable | 196 | 98 | |
| Dividend payable | 8 | — | |
| Liabilities in respect of business combinations | 6 | 9 | |
| Put options of non-controlling interests | 61 | 52 | |
| Total current liabilities | 1,330 | 1,138 | |
| LONG-TERM LIABILITIES: | — | — | |
| Loans from banks and others | 68 | 63 | |
| Debentures | 119 | 188 | |
| Lease liabilities | 108 | 120 | |
| Other long-term liabilities | 54,000 | 12 | |
| Deferred taxes | 83 | 43 | |
| Deferred revenues | 16 | 13 | |
| Liabilities in respect of business combinations | 13 | 9 | |
| Put options of non-controlling interests | 62 | 31 | |
| Employee benefit liabilities | 6 | 10 | |
| Total long-term liabilities | 475 | 487 | |
| COMMITMENTS AND CONTINGENCIES | — | — | |
| EQUITY | — | — | |
| Ordinary shares of NIS 1 par value - Authorized: 25,000,000 shares as of December 31, 2025 and 2024; Issued: 15,901,287 shares as of December 31, 2025 and 2024; Outstanding: 15,332,667 shares as of December 31, 2025 and 2024. | 4 | 4 | |
| Additional paid-in capital | 166 | 153 | |
| Retained earnings | 1,106 | 536 | |
| Accumulated other comprehensive income | 77 | −13 | |
| Treasury shares (568,620 shares as of December 31, 2025 and 2024) | 259,000 | 259,000 | |
| Total equity attributable to Formula Systems (1985) Ltd. shareholders | 1,353 | 679 | |
| Non-controlling interests | 425 | 710 | |
| Total equity | 1,778 | 1,389 | |
| Total liabilities and equity | 3,583 | 3,015 |
Consolidated Statement of Cash Flows
| Concept | Trend | Dec 31, 2025 2025-12-31 | Dec 31, 2024 2024-12-31 | Dec 31, 2023 2023-12-31 |
|---|---|---|---|---|
| Statement of cash flows [abstract] | — | — | — | |
| Cash flows from operating activities: | — | — | — | |
| Net income | 669 | 194 | 166 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | — | — | — | |
| Share of profits of companies accounted for at equity, net | −4 | −2 | −773,000 | |
| Depreciation and amortization | 153 | 115 | 122 | |
| Changes in value of debentures, net | 315,000 | 437,000 | 1 | |
| Increase in employee benefit liabilities | 4 | 699,000 | 3 | |
| Loss on disposal of subsidiaries, net of tax (Appendix D) | −1 | — | — | |
| Gain on disposal of discontinued operations, net of tax (Appendix D) | 578 | — | — | |
| Capital gain from Initial public offering of TSG | — | 4 | — | |
| Gain from secondary equity issuance of TSG | 9 | — | — | |
| Loss (gain) from sale of property, plants and equipment | −65,000 | 589,000 | 66,000 | |
| Share-based payment expenses | 31 | 16 | 19 | |
| Net finance expenses (income) related to bank loans and deposits | −8 | 1 | −833,000 | |
| Changes in deferred taxes, net | −8 | −12 | −8 | |
| Cash paid in respect of acquisitions of activities | — | −922,000 | −7 | |
| Change in liability in respect of business combinations | 3 | −2 | −2 | |
| Change in fair value of financial assets measured at fair value through profit or loss | — | — | 5,000 | |
| Amortization of premium and accrued interest on debt instruments at fair value through other comprehensive income | 101,000 | −27,000 | −114,000 | |
| Gain from revaluation of dividend preference derivative in TSG | — | −659,000 | −85,000 | |
| Effect of exchange rate on cash and cash equivalents held in currencies other than the functional currency | 7 | −350,000 | 991,000 | |
| Working capital adjustments: | — | — | — | |
| Decrease (increase) in inventories | 5 | 12 | −3 | |
| Decrease (increase) in trade receivables | 52 | −81 | 7 | |
| Decrease in other current and long-term accounts receivable | −16 | −2 | −6 | |
| Increase in trade payables | 24 | 40 | 19 | |
| Increase in other accounts payable and employees and payroll accrual | 48 | 45 | −25 | |
| Increase (decrease) in deferred revenues | −8 | 7 | 10 | |
| Net cash provided by operating activities | 382 | 324 | 295 | |
| Cash flows from investing activities: | — | — | — | |
| Payments for business acquisitions, net of cash acquired (Appendix C) | 136 | 50 | 37 | |
| Proceeds from disposal of subsidiary discontinued operation (Appendix D) | 676 | — | — | |
| Proceeds from sale of a subsidiary related to non-controlling interests (Appendix D) | −994,000 | — | — | |
| Cash paid in conjunction with deferred payments and contingent liabilities related to business combinations | −4 | −8 | −12 | |
| Loan extended to related party and others | — | — | 7 | |
| Purchase of intangible assets | 2 | 908,000 | 763,000 | |
| Purchase of investment measured using the equity method | — | 16 | — | |
| Purchase of other investments | — | — | 498,000 | |
| Purchase of financial assets measured at fair value through other comprehensive income | 380,000 | −585,000 | 1 | |
| Purchase of property and equipment | 16 | 16 | 17 | |
| Proceeds from maturity and sale of investments in instruments at fair value through other comprehensive income or loss, net | 4 | 5 | 699,000 | |
| Proceeds from sale of property and equipment | 1 | 783,000 | 1 | |
| Dividend from companies accounted for at equity | 6 | 162,000 | 68,000 | |
| Payment to former shareholders of consolidated company | 6 | 6 | — | |
| Change in short-term and long-term deposits | 56 | 24 | −51 | |
| Capitalization of software development and other costs | 10 | 12 | 15 | |
| Loan to an associate company | 165,000 | — | — | |
| Payment of liability related to the disposal of a subsidiary | 522,000 | — | — | |
| Deferred payment for acquisition of subsidiaries consolidated in prior periods | 3 | — | — | |
| Net cash provided )used( in investing activities | 564 | −78 | −139 | |
| Cash flows from financing activities: | — | — | — | |
| Exercise of employees’ stock options in subsidiaries | — | −98,000 | −5 | |
| Cash paid in conjunction with acquisitions of activities | 674,000 | 2 | 7 | |
| Dividend paid to non-controlling interests | 100 | 66 | 62 | |
| Dividend to Formula’s shareholders | 29 | 19 | 10 | |
| Short-term bank credit, net | 4 | 5 | 10 | |
| Repayment of long-term loans from banks and others | 102 | 93 | 83 | |
| Receipt of long-term loans from banks and others | −100 | −63 | −56 | |
| Receipt of short-term loans from banks and others | 12 | — | — | |
| Proceeds from issuance of debentures, net | — | 67 | — | |
| Proceeds from issuance of ordinary shares by subsidiaries | 84 | — | — | |
| Repayment of long-term liabilities to IIA | — | 3 | 394,000 | |
| Repayment of debentures | 107 | 69 | 60 | |
| Purchase of non-controlling interests | 468,000 | 5 | 3 | |
| Repayment of lease liabilities | 54 | 50 | 55 | |
| Cash paid due to exercise of put option by non-controlling interests | 14 | 2 | 13 | |
| Payment to non-controlling interests due to put option | 8 | 1 | 271,000 | |
| Net cash used by financing activities | −223 | −185 | −243 | |
| Effect of exchange rate changes on cash and cash equivalents | 50 | −5 | −5 | |
| Increase (decrease) in cash and cash equivalents | 772 | 56 | −92 | |
| Cash and cash equivalents at the end of the year | — | — | — | |
| Cash and cash equivalents at the end of the year | — | — | — | |
| Interest paid | −25 | −26 | −26 | |
| Interest received | 9 | 16 | 7 | |
| Taxes paid, net | −72 | −63 | −77 | |
| Purchase of property and equipment | 102,000 | 123,000 | 86,000 | |
| Intangible assets and goodwill incurred but unpaid at year end | — | 98,000 | 382,000 | |
| Contingent acquisition consideration | — | — | −124,000 | |
| Dividend payable to Formula’s shareholders | −9 | — | — | |
| Dividend payable to non-controlling interests | −3,000 | −16 | — | |
| Right-of-use asset recognized with corresponding lease liability | 36 | 83 | 45 | |
| Working capital (excluding cash and cash equivalents) | 17 | 3 | 10 | |
| Inventories | −436,000 | −256,000 | −4 | |
| Property and equipment | −2 | −1 | −242,000 | |
| Goodwill and intangible assets | −154 | −94 | −45 | |
| Right-of-use assets | −575,000 | — | −93,000 | |
| Other long-term assets | −2 | −3 | −2 | |
| Liabilities to banks and others | — | −1 | −7 | |
| Long-term liabilities | −9 | −422,000 | −282,000 | |
| Lease liabilities | −512,000 | — | −93,000 | |
| Deferred tax liability, net | 11 | 10 | 3 | |
| Dividend payable | −1 | — | — | |
| Liability to formerly shareholders | — | −8 | −1 | |
| Deferred payments and contingent consideration | 5 | 20 | 2 | |
| Redeemable non-controlling interests at acquisition date | 10 | — | — | |
| Non-controlling interests at acquisition date | 4 | 13 | 12 | |
| Total | −136 | −50 | −37 | |
| The subsidiaries’ assets and liabilities at date of sale: | — | — | — | |
| Working capital (excluding cash and cash equivalents) | −161 | — | — | |
| Property and equipment | 9 | — | — | |
| Financial assets measured at fair value through profit or loss | 300 | — | — | |
| Goodwill and intangible assets | 575 | — | — | |
| Deferred tax | 10 | — | — | |
| Right-of-use assets | 18 | — | — | |
| Other long-term assets | 89,000 | — | — | |
| Liabilities to banks and others | 860,000 | — | — | |
| Long-term liabilities | 63,000 | — | — | |
| Lease liabilities | 21 | — | — | |
| Deferred tax liability, net | 14 | — | — | |
| Dividend payable | 143,000 | — | — | |
| Liability in connection with the sale of a subsidiary for consideration in the form of non-controlling interests | 386,000 | — | — | |
| Capital reserve from transactions with non-controlling interests | 1 | — | — | |
| Reclassification of translation reserve to profit or loss upon disposal | 37 | — | — | |
| Non-controlling interests at acquisition date | 361 | — | — | |
| Redeemable non-controlling interests at acquisition date | 13 | — | — | |
| Gain on disposal and deconsolidation of a subsidiary | 577 | — | — | |
| Subsidiaries assets and liabilities at date of sale | 675 | — | — |